Louise Ford

10PUBLICATIONS
38CO-AUTHORS
Microbial ecologyCommunity ecology (excl. invasive species ecology)Medical parasitologyMedical devicesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2024
Targeting a microbiota Wolbachian aminoacyl-tRNA synthetase to block its pathogenic host.

Guillaume Hoffmann, Maria Lukarska, Rachel H Clare

|Apr 04, 2022
Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment.

Shannon Quek, Darren A N Cook, Yang Wu

|Mar 15, 2019
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.

Mark J Taylor, Thomas W von Geldern, Louise Ford

|Mar 01, 2019
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.

Thomas W von Geldern, Howard E Morton, Rick F Clark

|Jan 09, 2019
AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.

W David Hong, Farid Benayoud, Gemma L Nixon

|Jan 04, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides.

Rachel H Clare, Catherine Bardelle, Paul Harper

Pageof 2